Who we are

PharmaLex Belgium provides statistical expertise through consulting services, training and dedicated software to pharmaceutical and biopharmaceutical companies. Our goal is the same as the companies we support – to efficiently and consistently develop and deliver quality medicine to patients.

What makes us different?

Leveraging statistics is more than just applying statistical methods

  • We understand the entire product lifecycle, and provide holistic solutions focused on the patient
  • We ask questions so that we can use the right statistics to solve the right business problem. We apply “fit for purpose” statistics with the business problem in mind, considering simplicity, accuracy, and risk
  • We understand the science of your business. We have diverse backgrounds including biology, engineering, computing, and chemistry
  • We understand the regulatory environment: GxP, ICH, GAMP, FDA, EMEA, and have a full quality system
  • We are recognized experts in applying Bayesian methods to accelerate development , reduce resources, and manage risk
  • Today, as the PharmaLex network continues to grow, we are poised to deliver paradigm-changing solutions in a highly regulated environment that transcend geographies and specialisms, fulfilling the needs of an extended global client base.
  • Our strength and competencies stem from the multidisciplinary background of our team.
  • We draw from the combined knowledge of the whole spectrum of life sciences (including biology, biochemistry, pharmacology, engineering, food chemistry, medicine, nutritional science, pharmacy science, toxicology and veterinary medicine).
  • Our experts have many years of experience.

Local Contact

  • Francois De Witte
    Chief Financial Officer PharmaLex Belgium Rue Edouard Belin, 5
    1435 Mont-St-Guibert
    +32 10 46 10 10

    PharmaLex Belgium has a Data Protection Officer who can be contacted on dpo-plxstat@pharmalex.com

What our clients say about us

We are working with a number of large pharma companies and are looking to create a consortium of partners to collect feedback on expertise, availability and outcomes. If you would be interested in joining our consortium, please contact us on contact@pharmalex.com.

  • In these unprecedented times, PharmaLex continues to support all clients by meeting virtually and providing experienced, remote-based consultants.

    PharmaLex Team Thomas
    Thomas Dobmeyer, CEO PharmaLex
    CEO PharmaLex
  • Hard working and there when you need them

    Europe based large biotech
    Regulatory Manager
  • Pharmalex provided the resources we needed to compile Investigational Medicinal Product Dossiers for our biological products. The dossiers were delivered on time with the trusted quality we expected

    Small US Biopharmaceutical Company
    Sr Director Regulatory Affairs CMC
  • There was a close relationship between the regulatory strategy and the writing activities. You developed a fine-tuned regulatory strategy which will be a key factor to smooth the approval of our dossier.

    Large Pharma, Global
    VP Regulatory Strategy